The Latest Breaking News from NYSE

CTI BioPharma's Bone Marrow Cancer Drug Scores FDA Approval

The FDA approved CTI BioPharma Corp's (NASDAQ:CTIC) Vonjo (pacritinib) for treating adult patients with myelofibrosis, a type of bone marrow cancer with low blood platelets count. Pacritinib is a JAK inhibitor and will compete with Incyte Corporation's (NASDAQ:INCY) Jakafi and Bristol Myers Squibb's Co (NYSE:BMY) Inrebic, which were approved in 2011 and 2019, respectively for myelofibrosis. CTI…

Benzinga · Mar 1, 2022

10 Biggest Price Target Changes For Tuesday

Keybanc cut the price target on Workday, Inc. (NASDAQ: WDAY) from $345 to $312. Workday shares rose 5.7% to $242.00 in pre-market trading.

Benzinga · Mar 1, 2022

Twitter Is Ramping Up Bitcoin And Ethereum Related Offerings But That's Not Enough To Impress Cathie Wood Right Now

Cathie Wood-led Ark Investment Management on Monday sharply lowered its exposure in Twitter Inc (NYSE: TWTR) as it dumped 517,882 shares — estimated to be worth $18.4 million based — in the social media company that it was bullish on until late last year.

Benzinga · Mar 1, 2022

Here's How Full Truck Alliance Fared In Q4

Full Truck Alliance Co Ltd (NYSE:YMM) reported fourth-quarter FY21 net revenue growth of 68.1% year-on-year to $224.3 million, beating the consensus of $203.5 million. Growth Drivers: Revenues from freight matching services grew 85.7% Y/Y to $192.9 million due to increased revenues from freight brokerage services and growth in transaction commissions. The gross transaction value…

Benzinga · Mar 1, 2022

Here's Why Verizon, BlackRock Collaborated

Verizon Communications Inc (NYSE:VZ) looks to build a private 5G network for BlackRock Inc at its new Hudson Yards headquarters, juicing up rivalry with AT&T Inc (NYSE:T) and T-Mobile US Inc (NASDAQ:TMUS). Verizon said that the new 5G wireless technology could replace Wi-Fi and give BlackRock the ability to use applications like virtual reality and edge computing that require…

Benzinga · Mar 1, 2022

Darling Ingredients Q4 Earnings Top Estimates

Darling Ingredients Inc (NYSE:DAR) reported fourth-quarter FY21 sales growth of 28.5% year-on-year, to $1.31 billion, beating the consensus of $1.22 billion. The gross margin for the quarter expanded 20 basis points to 24.5%, and the gross profit rose 29.2% Y/Y to $321.1 million. The operating margin was 16.1%, and operating income for the…

Benzinga · Mar 1, 2022

A Peek Into The Markets: US Stock Futures Edge Lower Ahead Of Manufacturing Data; Crude Oil Surges 3%

Pre-open movers

Benzinga · Mar 1, 2022

67 Biggest Movers From Yesterday

Gainers  

Benzinga · Mar 1, 2022

5 Stocks To Watch For March 1, 2022

Some of the stocks that may grab investor focus today are:

Benzinga · Mar 1, 2022

Earnings Scheduled For March 1, 2022

  Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter.

Benzinga · Mar 1, 2022